Pharmacological modulation of central nociception in the management of chronic musculoskeletal pain

被引：0
作者：
Kuttikat, Anoop [1 ]
Shenker, Nicholas [1 ,2 ]
机构：
[1] Univ Cambridge Hosp NHS Fdn Trust, Addenbrookes Hosp, Dept Rheumatol, Cambridge, England
[2] Univ Cambridge, Dept Neurosci, Cambridge, England
来源：
PAIN MANAGEMENT | 2011年 / 1卷 / 06期
关键词：
D O I：
10.2217/PMT.11.63
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Chronic musculoskeletal pain, defined as pain lasting beyond the usual healing time of 6 weeks to 3 months, is a very common condition. It adversely affects the quality of life of patients and has a significant economic impact on our society. There is an ever increasing understanding of the pathophysiology of chronic pain. This has resulted in the effective use of various medications aimed at modulating both central and peripheral sensitizations. There are also new agents being developed based on fundamental research. The pharmacological agents used in the modulation of central nociception in chronic musculoskeletal pain are reviewed in this article.
引用
收藏
页码：549 / 556
页数：8
相关论文
共 49 条
  • [1] Gabapentin in the treatment of fibromyalgia - A randomized, double-blind, placebo-controlled, multicenter trial
    Arnold, Lesley M.
    Goldenberg, Don L.
    Stanford, Sharon B.
    Lalonde, Justine K.
    Sandhu, H. S.
    Keck, Paul E., Jr.
    Welge, Jeffrey A.
    Bishop, Fred
    Stanford, Kevin E.
    Hess, Evelyn V.
    Hudson, James I.
    [J]. ARTHRITIS AND RHEUMATISM, 2007, 56 (04): : 1336 - 1344
  • [2] A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder
    Arnold, LM
    Rosen, A
    Pritchett, YL
    D'Souza, DN
    Goldstein, DJ
    Iyengar, S
    Wernicke, JF
    [J]. PAIN, 2005, 119 (1-3) : 5 - 15
  • [3] A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder
    Arnold, LM
    Lu, YL
    Crofford, LJ
    Wohlreich, M
    Detke, MJ
    Iyengar, S
    Goldstein, DJ
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : 2974 - 2984
  • [4] Osteoarthritis and its association with muscle hyperalgesia: an experimental controlled study
    Bajaj, P
    Bajaj, P
    Graven-Nielsen, T
    Arendt-Nielsen, L
    [J]. PAIN, 2001, 93 (02) : 107 - 114
  • [5] Comparison of milnacipran, duloxetine and pregabalin in the formalin pain test and in a model of stress-induced ultrasonic vocalizations in rats
    Bardin, L.
    Gregoire, S.
    Aliaga, M.
    Malfetes, N.
    Vitton, O.
    Ladure, P.
    Newman-Tancredi, A.
    Depoortere, R.
    [J]. NEUROSCIENCE RESEARCH, 2010, 66 (02) : 135 - 140
  • [6] Posttranslational mechanisms of peripheral sensitization
    Bhave, G
    Gereau, RW
    [J]. JOURNAL OF NEUROBIOLOGY, 2004, 61 (01): : 88 - 106
  • [7] Bonica JJ., 1990, BONICAS MANAGEMENT P
  • [8] Genetics of chronic pain states
    Buskila, Dan
    [J]. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2007, 21 (03): : 535 - 547
  • [9] EULAR evidence-based recommendations for the management of fibromyalgia syndrome
    Carville, S. F.
    Arendt-Nielsen, S.
    Bliddal, H.
    Blotman, F.
    Branco, J. C.
    Buskila, D.
    Da Silva, J. A. P.
    Danneskiold-Samsoe, B.
    Dincer, F.
    Henriksson, C.
    Henriksson, K. G.
    Kosek, E.
    Longley, K.
    McCarthy, G. M.
    Perrot, S.
    Puszczewicz, M.
    Sarzi-Puttini, P.
    Silman, A.
    Spaeth, M.
    Choy, E. H.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (04) : 536 - 541
  • [10] Duloxetine, a centrally acting analgesic, in the treatment of patients with osteoarthritis knee pain: A 13-week, randomized, placebo-controlled trial
    Chappell, Amy S.
    Ossanna, Melissa J.
    Liu-Seifert, Hong
    Iyengar, Smriti
    Skljarevski, Vladimir
    Li, Linda Chunhong
    Bennett, Robert M.
    Collins, Harry
    [J]. PAIN, 2009, 146 (03) : 253 - 260
12345